Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report

BACKGROUND: Squamous cell carcinoma of head and neck (SCCHN) is the fifth most common cancer worldwide. Inhibition of epidermal growth factor receptor signaling has been shown to be a critical component of therapeutic option. Herein, we report a case of durable complete response to erlotinib. CASE S...

Descripción completa

Detalles Bibliográficos
Autores principales: Thinn, Mie Mie, Hsueh, Chung-Tzu, Hsueh, Chung-Tsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406195/
https://www.ncbi.nlm.nih.gov/pubmed/30863760
http://dx.doi.org/10.12998/wjcc.v7.i5.616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406195/
https://www.ncbi.nlm.nih.gov/pubmed/30863760
http://dx.doi.org/10.12998/wjcc.v7.i5.616

Ejemplares similares